This white paper has expired. Contact us for more information at info@darkreport.com
Stay up to date the lastest product Strengths, weaknesses, opportunities and threats. (SWOT) Many mid-sized hospitals now perform both immunoassay (IA) and infectious disease (ID) testing, but do not have the capital budget or floor space for a large integrated system. These labs require a single analyzer characterized by a small footprint, assay flexibility and high productivity that meets lab testing protocols. This article examines 5 analyzers currently in use and evaluates their productivity. The product review protocol consisted of observing each competitive system in an operating lab for 2 days. Detailed time study data and operator comments/feedback were collected. Additionally, the daily worklist of patient samples and ordered tests was recorded. These “real-world” worklists were then run on the ADVIA Centaur CP and the same detailed time study data was recorded. The observed lab operations and worklist comparisons were the basis of the productivity evaluation within a working lab environment. |
| Table of Contents
|
|
| Disclosure | Page: 2 |
| Preface | Page: 4 |
| Chapter 1. Study Methodology | Page: 6 |
| Chapter 2. Data Collection | Page: 8 |
| Chapter 3. Results -The Abbott AxSYM -The Beckman-Coulter Access2 -The Ortho ECiQ -The Roche Elecsys 2010 -Siemens ADVIA Centaur CP |
Page: 9 Page: 13 Page: 17 Page: 21 Page: 25 |
| Chapter 4. Summary | Page: 28 |
| Appendices -A-1 About Tim Baker -A-2 About Jared Williams -A-3 About Nexus Global Solutions -A-4 About Karen Appold -A-5 About DARK Daily -A-6 About The Dark Intelligence Group, Inc., and THE DARK REPORT -A-7 The Executive War College on Laboratory and Pathology Management |
Page: 33 Page: 34 Page: 35 Page: 36 Page: 37 Page: 38 Page: 39 |
| Terms of Use | Page: 42 |
